Description
ARA-290 10MG
10mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
ARA-290 10mg (also known as Cibinetide) is a specialized 11-amino acid peptide derived from the structure of Erythropoietin (EPO). Within experimental protocols, this molecule is analyzed for its unique ability to selectively bind to the Innate Repair Receptor (IRR) without stimulating red blood cell production. Research focuses on its potential to modulate inflammatory pathways, provide neuroprotection, and support tissue recovery mechanisms in various disease models. Explore our full range of Research Peptides.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | ARA-290 10mg (Cibinetide) |
| Sequence | Glp-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser |
| Molecular Formula | C51H84N16O21 |
| Molecular Weight | 1257.3 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 10 mg per vial |
| Grade | Laboratory Research Grade |
Research Application Areas
- Innate Repair Receptor (IRR) Activation: Study of the signaling pathways involved in tissue protection and repair.
- Neuropathic Pain Research: Analysis of the peptide’s potential to modulate small fiber neuropathy and inflammatory pain.
- Cytoprotection: Investigation into the stabilization of mitochondrial membranes and reduction of apoptosis in stressed cells.
- Anti-Inflammatory Mechanisms: Research on the suppression of pro-inflammatory cytokine production in chronic disease models.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.